These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 38048881)
1. Association between pan-immune-inflammation value and coronary slow flow phenomenon in patients with angiographically normal coronary arteries. Akkaya S; Cakmak U Int J Cardiol; 2024 Mar; 398():131631. PubMed ID: 38048881 [TBL] [Abstract][Full Text] [Related]
2. Could Pan-Immune-Inflammation Value be a Marker for the Diagnosis of Coronary Slow Flow Phenomenon? Kaplangoray M; Toprak K; Deveci E; Caglayan C; Şahin E Cardiovasc Toxicol; 2024 May; 24(5):519-526. PubMed ID: 38622332 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics in patients with coronary slow flow phenomenon: A retrospective study. Huang Q; Zhang F; Chen S; Dong Z; Liu W; Zhou X Medicine (Baltimore); 2021 Feb; 100(6):e24643. PubMed ID: 33578588 [TBL] [Abstract][Full Text] [Related]
4. Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon. Dai XT; Kong TZ; Zhang XJ; Luan B; Wang Y; Hou AJ BMC Cardiovasc Disord; 2022 Aug; 22(1):362. PubMed ID: 35941535 [TBL] [Abstract][Full Text] [Related]
5. Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries. Zhang XJ; Hou AJ; Luan B; Wang CF; Li JJ BMC Cardiovasc Disord; 2024 Jul; 24(1):358. PubMed ID: 39003493 [TBL] [Abstract][Full Text] [Related]
6. Anatomic properties of coronary arteries are correlated to the corrected thrombolysis in myocardial infarction frame count in the coronary slow flow phenomenon. Nie SP; Wang X; Geng LL; Liu BQ; Li J; Qiao Y; Liu XM; Luo TY; Dong JZ; Liu XH; Li JJ; Ma CS Coron Artery Dis; 2012 May; 23(3):174-80. PubMed ID: 22336658 [TBL] [Abstract][Full Text] [Related]
7. Clinical, demographic, risk factor and angiographic profile of coronary slow flow phenomenon: A single centre experience. Sanghvi S; Mathur R; Baroopal A; Kumar A Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S290-S294. PubMed ID: 30595277 [TBL] [Abstract][Full Text] [Related]
8. Analysis of correlative factors of female coronary slow-flow phenomenon: A retrospective study. Chen X; Zhang A; Xu Z; Yin Z; Wang C; Zhang J; Bian L Medicine (Baltimore); 2024 May; 103(21):e38262. PubMed ID: 38787982 [TBL] [Abstract][Full Text] [Related]
9. The relationship between triglyceride/high-density lipoprotein cholesterol ratio and coronary slow-flow phenomenon. Aciksari G; Cetinkal G; Kocak M; Atici A; Celik FB; Caliskan M Int J Cardiovasc Imaging; 2022 Jan; 38(1):5-13. PubMed ID: 34453654 [TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory predictors of coronary slow flow in coronary angiography. Ghaffari S; Tajlil A; Aslanabadi N; Separham A; Sohrabi B; Saeidi G; Pourafkari L Perfusion; 2017 Jan; 32(1):13-19. PubMed ID: 27412375 [TBL] [Abstract][Full Text] [Related]
11. Association of Interleukin-1 Gene cluster polymorphisms with coronary slow flow phenomenon. Mutluer FO; Ural D; Güngör B; Bolca O; Aksu T Anatol J Cardiol; 2018 Jan; 19(1):34-41. PubMed ID: 29339698 [TBL] [Abstract][Full Text] [Related]
12. Incremental value of three-dimensional echocardiography for evaluating left atrial function in patients with coronary slow flow phenomenon: a case control study. Li J; Wang Y; Zhao C; Zhu Q; Li G; Yang J; Jia D; Ma C Cardiovasc Ultrasound; 2020 Feb; 18(1):6. PubMed ID: 32054491 [TBL] [Abstract][Full Text] [Related]
13. Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon. Wang Y; Liu MJ; Yang HM; Ma CY; Jia PY; Jia DL; Hou AJ BMC Cardiovasc Disord; 2018 Jul; 18(1):138. PubMed ID: 29973151 [TBL] [Abstract][Full Text] [Related]
14. Echocardiographic and laboratory findings in coronary slow flow phenomenon: cross-sectional study and review. Seyyed Mohammadzad MH; Khademvatani K; Gardeshkhah S; Sedokani A BMC Cardiovasc Disord; 2021 May; 21(1):230. PubMed ID: 33952204 [TBL] [Abstract][Full Text] [Related]
15. Arterial elasticity in obese subjects with coronary slow flow phenomenon. Hussein O; Zidan J; Plich M; Gefen H; Klein R; Shestatski K; Abu-Jabal K; Zimlichman R Isr Med Assoc J; 2013 Dec; 15(12):753-7. PubMed ID: 24449979 [TBL] [Abstract][Full Text] [Related]
16. Feasibility Study of Transthoracic Echocardiography for Coronary Slow Flow Phenomenon Evaluation: Validation by Coronary Angiography. Li Y; Fang F; Ma N; Li R; Sun Q; Yang J; Nie S; Yu CM; Yang Y Microcirculation; 2016 May; 23(4):277-82. PubMed ID: 26991324 [TBL] [Abstract][Full Text] [Related]
17. Association Between Primary Coronary Slow-Flow Phenomenon and Epicardial Fat Tissue. Weferling M; Vietheer J; Keller T; Fischer-Rasokat U; Hamm CW; Liebetrau C J Invasive Cardiol; 2021 Jan; 33(1):E59-E64. PubMed ID: 33385988 [TBL] [Abstract][Full Text] [Related]
18. New indicator of cellular ischemia in coronary slow-flow phenomenon: Cell-free DNA. Yolcu M; Dogan A; Kurtoglu N; Hancer VS; Gürbüzel M Turk Kardiyol Dern Ars; 2020 Sep; 48(6):558-565. PubMed ID: 32955030 [TBL] [Abstract][Full Text] [Related]
19. Coronary slow flow--prevalence and clinical correlations. Hawkins BM; Stavrakis S; Rousan TA; Abu-Fadel M; Schechter E Circ J; 2012; 76(4):936-42. PubMed ID: 22293446 [TBL] [Abstract][Full Text] [Related]
20. Association between Pan-Immune-Inflammation Value and Contrast-Induced Nephropathy with Coronary Angiography. Akkaya S; Cakmak U Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929630 [No Abstract] [Full Text] [Related] [Next] [New Search]